| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 9 | |
| #2 | WIPO (World Intellectual Property Organization) | 5 | |
| #3 | EPO (European Patent Office) | 4 | |
| #4 | China | 3 | |
| #5 | Republic of Korea | 3 | |
| #6 | Australia | 2 | |
| #7 | Canada | 2 | |
| #8 | Mexico | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Medical technology | |
| #4 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds | |
| #4 | Climate change adaptation technologies | |
| #5 | Electrotherapy |
| # | Name | Total Patents |
|---|---|---|
| #1 | Orlemans Everardus O M | 17 |
| #2 | Eaves Jeron | 6 |
| #3 | Barta Thomas | 6 |
| #4 | Hanson Gunnar | 6 |
| #5 | Huang Kenneth He | 6 |
| #6 | Geng Lifeng | 6 |
| #7 | Veal James | 6 |
| #8 | Hinkley Lindsay | 6 |
| #9 | Hughes Philip F | 5 |
| #10 | Haynes Barton F | 2 |
| Publication | Filing date | Title |
|---|---|---|
| US2019269656A1 | Combination Therapies Using Indazolylbenzamide Derivatives for the Treatment of Cancer | |
| AU2017268356A1 | Combination therapies using indazolylbenzamide derivatives for the treatment of cancer | |
| WO2017059434A1 | Use of tetrahydroindazolylbenzamide and tetrahydroindolylbenzamide derivatives for the treatment of cancer | |
| US2016143884A1 | Use of tetrahydroindazolylbenzamide and tetrahydroindolylbenzamide derivatives for the treatment of human immunodeficiency virus (hiv) and acquired immune deficiency syndrome (aids) | |
| EP3191473A1 | Indazolyl- and indolyl-benzamide derivatives |